← Open Payments lookup

EBERECHI ANI: Open Payments

NPI 1801332051 · FONTANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,800 in 206 payments from 13 companies in 2025. Trend: 2023 $2,278 · 2024 $2,146 · 2025 $3,800

Food & beverage: $3,800
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.41$701
Alkermes, Inc.35$636
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$629
Teva Pharmaceuticals USA, Inc.20$363
Janssen Pharmaceuticals, Inc14$347
Vanda Pharmaceuticals Inc.16$326
ABBVIE INC.16$195
Lundbeck LLC9$183
Axsome Therapeutics, Inc.13$149
Neurocrine BioSciences, Inc.4$110

Products named: REXULTI, CAPLYTA, ARISTADA, AUSTEDO XR, INVEGA SUSTENNA, FANAPT, ABILIFY ASIMTUFII, VRAYLAR.

Industry payments across CA — which companies pay providers there.